MedPath

Ayurvedic management in Benign Prostatic Hyperplasia

Not yet recruiting
Conditions
Benign prostatic hyperplasia withlower urinary tract symptoms. Ayurveda Condition: MUTRAGHATAH,
Registration Number
CTRI/2025/06/088484
Lead Sponsor
S.V. Ayurvedic College and Hospital
Brief Summary

The Vatashtheela Mutraghata reflects the symptoms of urine retention, incomplete voiding, dribbling, hesitancy, dysuria, straining during urination etc. These are feature of Lower Urinary Tract Symptoms and can be co–related with Benign Prostatic Hyperplasia in modern parlance. Being prostatic hyperplasia is one of the most prevalent obstructive uropathy of advanced age group people above the incidence has been estimated that 5-10% of men at their age of 40 have Prostatic enlargement & 80% by their age of 80 have evidence of BPH. Clinical features of BPH are hesitancy, dysuria, frequency, urgency, haematuria, pain, retention of urine renal failure, prostatism stream of urine, straining during micturition etc. and often features of acute or chronic retention of urine and uraemia also occurs during progression of disease.

Much advancement both technical and surgical nature have come into existence but still satisfactory treatment of the problemis not found in the modern surgery and urology. The methods like TURP (Trans Urethral Resection of Prostate), TUNA (Trans Urethral Needle Ablation), TUMT (Trans Urethral Microwave Thermotherapy), High-intensity focused ultrasound, TUE(Trans Urethral Electro vaporization, water induced thermotherapy and prostatic stent insertion are in practice but still not comprehensive.

In Ayurveda elaborated description regarding the management of Astheela is found across the samhitas and later works of medieval and modern period of Ayurveda. As discussed earlier the main cause for formation of the disease is Vatadosha, which is either in vridhiavastha or in avrutaavastha, Other contributory doshas are kapha and pitta.

The major chikista sutra formulated for these conditions includes the measures of pacifying Vata like Avagahaswedam, Uttaravasti and other procedures causing the Vatanulomanam. There are many drugs and compounds known to have good effect on Prosate and its pathology.

Benign Prostatic Hyperplasia is a condition which left untreated may lead to acute urinary retention, urinary tract infections, renal failure in due course of time. In modern system of medicines, Benign Prostatic Hyperplasia is managed with both conservative and surgical treatment modalities, but they are too expensive. The surgical correction also has potential complications including stricture of urethra, incontinence of urine. In Ayurveda, the management of Benign Prostatic Hyperplasia is done by adopting the principles of mutrakrcchra and mutraghata chikitsa,mutravegadharanajanya vikara cikitsa and granthi cikitsa which include avapidaka snehapana, vasti, ksara prayoga.

Thus the present study is entilted as  **A CLINICAL EVALUATION OF USHEERADYA TAILAM UTTARBASTI** **THE MANAGEMENT OF MUTRAGHATA (BPH)**

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Male
Target Recruitment
60
Inclusion Criteria
  • Patient diagnosis confirmed by USG.
  • Patients having the sign and symptoms of mutraghata BPH.
Exclusion Criteria
  • 1.Age below 45 years.
  • 2.Patients suffering from malignancy, congenital deformities of urogenital tract or any other pelvic pathology.
  • 3.Uncontrolled Hypertension, Diabetic Mellitus.
  • 4.Urogenital tuberculosis.
  • 5.Paralysis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the clinical efficacy of Usiradya taila Uttarbasti in reducing the size of the prostate and also reducing the post void residual urine in Benign ProstaticDURATION 1 Month | Patient is given Uttarvasti on every alternate day for 1 week for 4 times in a | week in the First sitting. | And given the gap for 2 weeks, and adviced to come for 2 nd sitting of uttar | vasti | Investigation and Assesment is done before treatment and after 2 sittings.
Hyperplasia.DURATION 1 Month | Patient is given Uttarvasti on every alternate day for 1 week for 4 times in a | week in the First sitting. | And given the gap for 2 weeks, and adviced to come for 2 nd sitting of uttar | vasti | Investigation and Assesment is done before treatment and after 2 sittings.
Secondary Outcome Measures
NameTimeMethod
To evaluate the clinical efficacy of Dhanvatara tailam Uttara basti in reducing the size of the prostate & also reducing the post void residual urine in Benign Prostatic Hyperplasia.To Compare the efficacies of Usiradya taila Uttarbasti & Dhanvantara tailam Uttar

Trial Locations

Locations (1)

S.V. Ayurvedic College and Hospital

🇮🇳

Chittoor, ANDHRA PRADESH, India

S.V. Ayurvedic College and Hospital
🇮🇳Chittoor, ANDHRA PRADESH, India
Dr Kokku Lakshmi Manogna
Principal investigator
8074329023
klakshmimanogna@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.